Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients
Clinical trial NCT06417489 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06417489
- Sponsor
- Peking University First Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-31
- Primary completion
- 2026-05-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.